STRATA CRITICAL MEDICAL, INC. Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Earnings Per Share
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted · last filed 2024-11-12
- STRATA CRITICAL MEDICAL, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2024-09-30 was $0.00.
- STRATA CRITICAL MEDICAL, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2023-09-30 was -$22.00K.
- STRATA CRITICAL MEDICAL, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2023-06-30 was $0.00.
- STRATA CRITICAL MEDICAL, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2022-12-31 was $0.00.
- STRATA CRITICAL MEDICAL, INC. undistributed earnings (loss) allocated to participating securities, diluted for fiscal 2022 was $0.00.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 3 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 6 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 9 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2023-09-30 | -$22.00K 10-Q · filed 2024-11-12 | -$22.00K derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | -$256.00K derived: sum of 3 quarters · filed 2023-11-08 | $0.00 10-K · filed 2023-03-16 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | -$256.00K derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | |
| 2022-06-30 | -$256.00K 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||
| 2021-12-31 | -$17.00K 10-K · filed 2023-03-16 | -$17.00K derived: sum of 2 quarters · filed 2023-03-16 | -$17.00K derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-09-30 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | $0.00 8-K · filed 2023-01-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |